Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

150 kHz electromagnetic radiation might help improve PCOS in rats.

SM-215 promotes hair growth by improving the environment around hair follicles.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.